Triarylimidazoles
    5.
    发明授权
    Triarylimidazoles 失效
    三芳基咪唑

    公开(公告)号:US06465493B1

    公开(公告)日:2002-10-15

    申请号:US09958639

    申请日:2001-10-09

    IPC分类号: A61K3144

    摘要: Compounds of formula (I) or a pharmaceutically acceptable salt thereof: wherein R1, R2 and R3 are various substituent groups; and one of X1 and X2 is N or CR′, and the other is NR′ or CHR′ wherein R′ is hydrogen, OH, C1-6alkyl, or C3-7cycloalkyl; or when one of X1 and X2 is N or CR′ then the other may be S or O; and their use as pharmaceuticals.

    摘要翻译: 式(I)化合物或其药学上可接受的盐:其中R1,R2和R3是各种取代基; 且X 1和X 2的一个为N或CR',另一个为NR'或CHR',其中R'为氢,OH,C 1-6烷基或C 3-7环烷基; 或者当X1和X2之一为N或CR'时,另一个可以是S或O;以及它们作为药物的用途。

    NF-κB inhibitors
    6.
    发明授权
    NF-κB inhibitors 失效
    NF-κB抑制剂

    公开(公告)号:US07166639B2

    公开(公告)日:2007-01-23

    申请号:US10491710

    申请日:2002-10-04

    IPC分类号: A61K31/38 C07D333/36

    CPC分类号: C07D333/36 C07D333/38

    摘要: The present invention provides novel compounds and methods for using them to treat diseases with aminothiophene inhibitors of IKK-β phosphorylation of IκB. In so doing these aminothiophene inhibitors block pathological activation of transcription factor NF-κB in which diseases excessive activation of NF-κB is implicated.

    摘要翻译: 本发明提供了使用它们用IkappaB的IKK-β磷酸化的氨基噻吩抑制剂治疗疾病的新型化合物和方法。 在这样做时,这些氨基噻吩抑制剂阻断转录因子NF-κB的病理活化,其中涉及NF-κB的过度活化。